More Articles Back to Article

Aligning Stakeholder Partnerships in Latin America

Best Practices from Cuba and Mexico

As the healthcare and regulatory landscape evolves in Latin America, early dialogue and enhanced partnerships between biopharmaceutical industry stakeholders, and streamlined coordination among healthcare and regulatory agencies, are critical to expedite decision-making, promote increasingly sophisticated systems and data-sharing, and leverage global ecosystems and synergies in response to emerging regional challenges.